この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 1998/1/271 分で読めます
Xytronyx, Inc.; Premarket Approval of the Periogard Periodontal Tissue Monitor
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is announcing its approval of the application by Xytronyx, Inc., San Diego, CA, for premarket approval, under the Federal Food, Drug, and Cosmetic Act (the act), of the Periogard Periodontal Tissue Monitor (PTM). After reviewing the recommendation of the Devices Panel, FDA's Center for Devices and Radiological Health (CDRH) notified the applicant, by letter of June 23, 1997, of the approval of the application.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →